WHWK
Whitehawk Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$200.78M
P/E Ratio
—
EPS
$-2.49
Beta
0.77
52W High
$5.50
52W Low
$1.57
50-Day MA
$4.13
200-Day MA
$2.96
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
2.66
PEG Ratio
—
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-99.41M |
| EBITDA | $-122.68M |
| Operating Margin | 0.00% |
| Return on Equity | -68.50% |
| Return on Assets | -42.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.89 |
| Price-to-Book | 1.72 |
| Price-to-Sales (TTM) | 30.04 |
| EV/Revenue | 8.32 |
| EV/EBITDA | -0.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $49.45M |
| Float | $18.06M |
| % Insiders | 13.41% |
| % Institutions | 72.47% |
Historical Volatility
HV 10-Day
69.92%
HV 20-Day
75.52%
HV 30-Day
96.20%
HV 60-Day
84.46%
HV Rank
85.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($6.50 target)
1
Strong Buy2
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026